Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,7195 USD | +2,79 % | +6,51 % | -19,16 % |
Resumen de negocios
Número de empleados: 6
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stephan Jackman
CEO | Chief Executive Officer | 48 | 20/11/18 |
David Katzoff
DFI | Director of Finance/CFO | 63 | 01/11/19 |
William Horne
CHM | Chairman | 55 | 01/06/16 |
Henry Nisser
BRD | Director/Board Member | 56 | 01/05/19 |
James Turner
LAW | General Counsel | 49 | 01/04/21 |
Kenneth Cragun
PRN | Corporate Officer/Principal | 63 | 01/10/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mark Gustafson
BRD | Director/Board Member | 64 | 01/06/21 |
Todd Ault
FOU | Founder | 54 | 25/02/16 |
William Horne
CHM | Chairman | 55 | 01/06/16 |
Jeffrey Oram
BRD | Director/Board Member | 56 | 01/06/21 |
Henry Nisser
BRD | Director/Board Member | 56 | 01/05/19 |
Lynne McGrath
BRD | Director/Board Member | 69 | 01/06/21 |
Stephan Jackman
CEO | Chief Executive Officer | 48 | 20/11/18 |
Andrew Woo
BRD | Director/Board Member | 61 | 01/06/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 6 866 846 | 4 831 824 ( 70,36 %) | 0 | 70,36 % |
Información de la empresa
Alzamend Neuro, Inc.
3480 Peachtree Road NE Suite 103
30326, Atlanta
+844 722 6333
http://www.alzamend.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-19,16 % | 4,94 M | |
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción ALZN
- Empresa Alzamend Neuro, Inc.